| 1 | Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis | 1.9 | 4 | Citations (PDF) |
| 2 | MRAnnotator: multi-anatomy and many-sequence MRI segmentation of 44 structures 2025, 2, | | 4 | Citations (PDF) |
| 3 | Modeling the fluid dynamics of mitral valve for clinical applications and surgical mitral valve repair | 3.7 | 1 | Citations (PDF) |
| 4 | Multiplexed imaging of radionuclides | 22.4 | 11 | Citations (PDF) |
| 5 | Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions | 11.5 | 24 | Citations (PDF) |
| 6 | An assessment of PET and CMR radiomic features for the detection of cardiac sarcoidosis | 1.2 | 7 | Citations (PDF) |
| 7 | A review of self‐supervised, generative, and few‐shot deep learning methods for data‐limited magnetic resonance imaging segmentation | 2.4 | 39 | Citations (PDF) |
| 8 | Uncovering atherosclerotic cardiovascular disease by PET imaging | 35.5 | 33 | Citations (PDF) |
| 9 | Unveiling the heart’s silent whisperer: study of stress and the brain–heart connection in Europe | 2.2 | 2 | Citations (PDF) |
| 10 | Rethinking Heart Attack Prevention | 2.3 | 5 | Citations (PDF) |
| 11 | Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy | 32.2 | 28 | Citations (PDF) |
| 12 | Trained immunity suppression determines kidney allograft survival | 4.5 | 9 | Citations (PDF) |
| 13 | Comprehensive Assessment of Physiological and Psychological Responses to Virtual Reality Experiences 2024, 1, 227-241 | | 8 | Citations (PDF) |
| 14 | Performance of spiral UTE-MRI of the lung in post-COVID patients | 1.8 | 14 | Citations (PDF) |
| 15 | Interstitial lung disease diagnosis and prognosis using an AI system integrating longitudinal data | 13.7 | 72 | Citations (PDF) |
| 16 | Exploring the Utility of Cardiovascular Magnetic Resonance Radiomic Feature Extraction for Evaluation of Cardiac Sarcoidosis | 2.8 | 5 | Citations (PDF) |
| 17 | Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells | 22.4 | 81 | Citations (PDF) |
| 18 | 68
Ga-Dotatate Hybrid Positron Emission Tomography/Magnetic Resonance Imaging for Noninvasive Early Detection of Heart Transplant Rejection | 2.9 | 2 | Citations (PDF) |
| 19 | Deep Learning for Automated Measurement of Patellofemoral Anatomic Landmarks | 3.2 | 11 | Citations (PDF) |
| 20 | JoVE Video Dataset 2023, , | | 0 | Citations (PDF) |
| 21 | Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images | 0.3 | 0 | Citations (PDF) |
| 22 | Implications of the Use of Artificial Intelligence Predictive Models in Health Care Settings | 9.6 | 42 | Citations (PDF) |
| 23 | Discovery Viewer (DV): Web-Based Medical AI Model Development Platform and Deployment Hub | 3.2 | 3 | Citations (PDF) |
| 24 | Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis | 6.1 | 20 | Citations (PDF) |
| 25 | Non-invasive imaging as the cornerstone of cardiovascular precision medicine | 1.4 | 35 | Citations (PDF) |
| 26 | Exploring the Utility of Radiomic Feature Extraction to Improve the Diagnostic Accuracy of Cardiac Sarcoidosis Using FDG PET | 2.4 | 10 | Citations (PDF) |
| 27 | Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation | 3.4 | 44 | Citations (PDF) |
| 28 | Evaluation of a machine learning approach utilizing wearable data for prediction of SARS-CoV-2 infection in healthcare workers | 2.4 | 20 | Citations (PDF) |
| 29 | Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4 | 37.9 | 80 | Citations (PDF) |
| 30 | Subclinical Atherosclerosis in Young, Socioeconomically Vulnerable Hispanic and Non-Hispanic Black Adults | 2.3 | 9 | Citations (PDF) |
| 31 | RadImageNet: An Open Radiologic Deep Learning Research Dataset for Effective Transfer Learning | 8.0 | 259 | Citations (PDF) |
| 32 | Inflammatory Diseases of the Aorta | 2.3 | 11 | Citations (PDF) |
| 33 | Sleep apnea and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA): leveraging state-of-the-art vascular imaging | 1.2 | 3 | Citations (PDF) |
| 34 | Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19 | 4.2 | 33 | Citations (PDF) |
| 35 | Prospective Motion Correction for Brain MRI Using an External Tracking System | 2.3 | 7 | Citations (PDF) |
| 36 | AKI in Hospitalized Patients with COVID-19 | 0.4 | 646 | Citations (PDF) |
| 37 | A leucopoietic-arterial axis underlying the link between ambient air pollution and cardiovascular disease in humans | 2.2 | 65 | Citations (PDF) |
| 38 | Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study | 2.3 | 7 | Citations (PDF) |
| 39 | Magnetization‐prepared GRASP MRI for rapid 3D T1 mapping and fat/water‐separated T1 mapping | 2.8 | 54 | Citations (PDF) |
| 40 | A modular approach toward producing nanotherapeutics targeting the innate immune system | 10.9 | 41 | Citations (PDF) |
| 41 | Prosaposin mediates inflammation in atherosclerosis | 12.5 | 95 | Citations (PDF) |
| 42 | Automated detection of critical findings in multi-parametric brain MRI using a system of 3D neural networks | 3.4 | 29 | Citations (PDF) |
| 43 | Combining Initial Radiographs and Clinical Variables Improves Deep Learning Prognostication in Patients with COVID-19 from the Emergency Department | 8.0 | 54 | Citations (PDF) |
| 44 | Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model | 3.6 | 5 | Citations (PDF) |
| 45 | Scan-rescan measurement repeatability of 18F-FDG PET/MR imaging of vascular inflammation | 1.8 | 9 | Citations (PDF) |
| 46 | Testing the Effects of Disease‐Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial | 2.2 | 13 | Citations (PDF) |
| 47 | Atherosclerosis inflammation and burden in young adult smokers and vapers measured by PET/MR | 1.5 | 15 | Citations (PDF) |
| 48 | Predictive Approaches for Acute Dialysis Requirement and Death in COVID-19 | 4.2 | 28 | Citations (PDF) |
| 49 | Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular Disease | 6.0 | 16 | Citations (PDF) |
| 50 | Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics | 2.2 | 18 | Citations (PDF) |
| 51 | Portable Chest Radiography as an Exclusionary Test for Adverse Clinical Outcomes During the COVID-19 PandemicChest, 2021, 160, 238-248 | 1.0 | 5 | Citations (PDF) |
| 52 | Posttraumatic Stress Disorder and Cardiovascular Disease | 11.1 | 131 | Citations (PDF) |
| 53 | Novel non-invasive assessment of upper airway inflammation in obstructive sleep apnea using positron emission tomography/magnetic resonance imaging | 1.5 | 6 | Citations (PDF) |
| 54 | A neurobiological link between transportation noise exposure and metabolic disease in humans | 2.7 | 19 | Citations (PDF) |
| 55 | Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes | 1.3 | 33 | Citations (PDF) |
| 56 | GAMER MRI: Gated-attention mechanism ranking of multi-contrast MRI in brain pathology | 3.3 | 6 | Citations (PDF) |
| 57 | Improvement of magnetic resonance imaging using a wireless radiofrequency resonator array | 3.4 | 34 | Citations (PDF) |
| 58 | Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall | 3.8 | 30 | Citations (PDF) |
| 59 | Trained immunity in organ transplantation | 4.5 | 105 | Citations (PDF) |
| 60 | Noninvasive Imaging to Assess Atherosclerotic Plaque Composition and Disease Activity | 6.1 | 75 | Citations (PDF) |
| 61 | An iterative sparse deconvolution method for simultaneous multicolor 19F‐MRI of multiple contrast agents | 2.8 | 30 | Citations (PDF) |
| 62 | Different Lifestyle Interventions in Adults From Underserved Communities | 2.3 | 16 | Citations (PDF) |
| 63 | Assessing the qualitative and quantitative impacts of simple two-class vs multiple tissue-class MR-based attenuation correction for cardiac PET/MR | 1.8 | 6 | Citations (PDF) |
| 64 | A neurobiological mechanism linking transportation noise to cardiovascular disease in humans | 2.2 | 151 | Citations (PDF) |
| 65 | Challenges in Cardiac and Pulmonary Sarcoidosis | 2.3 | 199 | Citations (PDF) |
| 66 | Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis | 4.6 | 133 | Citations (PDF) |
| 67 | 18F-fluoride PET/MR in cardiac amyloid: A comparison study with aortic stenosis and age- and sex-matched controls | 1.8 | 23 | Citations (PDF) |
| 68 | Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons | 6.6 | 36 | Citations (PDF) |
| 69 | A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis | 3.3 | 17 | Citations (PDF) |
| 70 | Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint InhibitionCell, 2020, 183, 786-801.e19 | 33.6 | 202 | Citations (PDF) |
| 71 | Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19 | 2.3 | 198 | Citations (PDF) |
| 72 | Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 | 2.3 | 415 | Citations (PDF) |
| 73 | Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging | 1.4 | 44 | Citations (PDF) |
| 74 | Disentangling the Links Between Psychosocial Stress and Cardiovascular Disease | 2.9 | 280 | Citations (PDF) |
| 75 | Exposure to Air Pollution Disrupts Circadian Rhythm through Alterations in Chromatin Dynamics | 3.5 | 58 | Citations (PDF) |
| 76 | Artificial intelligence–enabled rapid diagnosis of patients with COVID-19 | 33.0 | 947 | Citations (PDF) |
| 77 | Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging | 6.0 | 9 | Citations (PDF) |
| 78 | Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 | 2.3 | 852 | Citations (PDF) |
| 79 | Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19 | 8.7 | 287 | Citations (PDF) |
| 80 | Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse | 11.1 | 46 | Citations (PDF) |
| 81 | Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection | 2.3 | 685 | Citations (PDF) |
| 82 | Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City | 5.2 | 212 | Citations (PDF) |
| 83 | Atherosclerosis Immunoimaging by Positron Emission Tomography | 6.0 | 32 | Citations (PDF) |
| 84 | Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection | 8.7 | 2,213 | Citations (PDF) |
| 85 | CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) | 8.7 | 2,270 | Citations (PDF) |
| 86 | Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging | 32.2 | 60 | Citations (PDF) |
| 87 | Ultra-high resolution, 3-dimensional magnetic resonance imaging of the atherosclerotic vessel wall at clinical 7T | 2.3 | 4 | Citations (PDF) |
| 88 | Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species | 12.5 | 69 | Citations (PDF) |
| 89 | Hybrid PET-MR list-mode kernelized expectation maximization reconstruction | 2.1 | 44 | Citations (PDF) |
| 90 | Summary of the First ISMRM–SNMMI Workshop on PET/MRI: Applications and Limitations | 5.1 | 39 | Citations (PDF) |
| 91 | Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease | 2.3 | 172 | Citations (PDF) |
| 92 | Advanced Imaging in Cardiac Sarcoidosis | 5.1 | 44 | Citations (PDF) |
| 93 | Advances in Therapies and Imaging for Systemic Vasculitis | 6.0 | 30 | Citations (PDF) |
| 94 | Child Health Promotion in Underserved Communities | 2.3 | 56 | Citations (PDF) |
| 95 | Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis | 2.3 | 302 | Citations (PDF) |
| 96 | Amygdalar Metabolic Activity Independently Associates With Progression of Visceral Adiposity | 4.0 | 26 | Citations (PDF) |
| 97 | Cardiovascular 18F-fluoride positron emission tomography-magnetic resonance imaging: A comparison study | 1.8 | 31 | Citations (PDF) |
| 98 | Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis | 6.1 | 90 | Citations (PDF) |
| 99 | Effect of PET-MR Inconsistency in the Kernel Image Reconstruction Method | 2.4 | 27 | Citations (PDF) |
| 100 | Amygdalar activity predicts future incident diabetes independently of adiposity | 2.7 | 39 | Citations (PDF) |
| 101 | Hybrid PET- and MR-driven attenuation correction for enhanced 18F-NaF and 18F-FDG quantification in cardiovascular PET/MR imaging | 1.8 | 23 | Citations (PDF) |
| 102 | Carotid Artery Remodeling Is Segment Specific | 6.0 | 50 | Citations (PDF) |
| 103 | Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study | 1.5 | 18 | Citations (PDF) |
| 104 | Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates | 22.4 | 126 | Citations (PDF) |
| 105 | PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis | 2.3 | 52 | Citations (PDF) |
| 106 | Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis | 6.1 | 31 | Citations (PDF) |
| 107 | High-Density Lipoprotein Nanobiologics for Precision Medicine | 17.0 | 78 | Citations (PDF) |
| 108 | New methods to image unstable atherosclerotic plaques | 1.5 | 63 | Citations (PDF) |
| 109 | Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis | 6.1 | 184 | Citations (PDF) |
| 110 | Material decomposition in an arbitrary number of dimensions using noise compensating projection | 1.5 | 1 | Citations (PDF) |
| 111 | Correction of respiratory and cardiac motion in cardiac PET/MR using MR-based motion modeling | 3.1 | 47 | Citations (PDF) |
| 112 | P30 68Ga-DOTATATE PET IDENTIFIES MYOCARDIAL INFLAMMATION AND BONE MARROW MONOCYTE MOBILISATION AFTER MYOCARDIAL INFARCTION | 5.5 | 0 | Citations (PDF) |
| 113 | Monocyte and Macrophage Dynamics in the Cardiovascular System | 2.3 | 54 | Citations (PDF) |
| 114 | Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life | 4.0 | 88 | Citations (PDF) |
| 115 | Nanoimmunotherapy to treat ischaemic heart disease | 35.5 | 58 | Citations (PDF) |
| 116 | Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment | 2.2 | 126 | Citations (PDF) |
| 117 | Comparison of Inter‐Observer Bias between Low Resolution and High Resolution Scans using 3T and 7T Scanners | 0.6 | 0 | Citations (PDF) |
| 118 | Real‐Time Monitoring of Nanoparticle Formation by FRET Imaging | 1.4 | 8 | Citations (PDF) |
| 119 | Real‐Time Monitoring of Nanoparticle Formation by FRET Imaging | 14.4 | 35 | Citations (PDF) |
| 120 | Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study | 62.1 | 600 | Citations (PDF) |
| 121 | Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease | 13.7 | 148 | Citations (PDF) |
| 122 | Coronary Artery PET/MR Imaging | 6.1 | 101 | Citations (PDF) |
| 123 | Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems–Biology for Promotion of Health (FAMILIA) | 2.9 | 20 | Citations (PDF) |
| 124 | Applying nanomedicine in maladaptive inflammation and angiogenesis | 15.4 | 62 | Citations (PDF) |
| 125 | Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis | 15.3 | 183 | Citations (PDF) |
| 126 | 3D black blood MR angiography of the carotid arteries. A simple sequence for plaque hemorrhage and stenosis evaluation | 1.8 | 14 | Citations (PDF) |
| 127 | Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging | 3.8 | 16 | Citations (PDF) |
| 128 | Vascular disease in cocaine addiction | 1.5 | 138 | Citations (PDF) |
| 129 | Cap inflammation leads to higher plaque cap strain and lower cap stress: An MRI-PET/CT-based FSI modeling approach | 2.2 | 34 | Citations (PDF) |
| 130 | Cardiovascular Immunotherapy and the Role of Imaging | 6.0 | 6 | Citations (PDF) |
| 131 | MR/PET Imaging of the Cardiovascular System | 6.1 | 88 | Citations (PDF) |
| 132 | Arterial Thrombus Stability | 2.3 | 59 | Citations (PDF) |
| 133 | Integrating nanomedicine and imaging | 2.5 | 6 | Citations (PDF) |
| 134 | Unraveling Vascular Inflammation | 2.3 | 70 | Citations (PDF) |
| 135 | Social stress induces neurovascular pathology promoting depression | 17.1 | 950 | Citations (PDF) |
| 136 | A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis | 11.0 | 54 | Citations (PDF) |
| 137 | Vessel wall characterization using quantitative MRI: what’s in a number? | 1.6 | 41 | Citations (PDF) |
| 138 | Non-invasive imaging of atherosclerosis regression with magnetic resonance to guide drug development | 1.5 | 12 | Citations (PDF) |
| 139 | The Role of Imaging in Aortic Valve Disease | 0.6 | 20 | Citations (PDF) |
| 140 | Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis | 13.1 | 134 | Citations (PDF) |
| 141 | Phantom study to determine optimal PET reconstruction parameters for PET/MR imaging of
90
Y microspheres following radioembolization | 1.5 | 11 | Citations (PDF) |
| 142 | Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy | 13.7 | 111 | Citations (PDF) |
| 143 | Optimization and Reproducibility of Aortic Valve 18F-Fluoride Positron Emission Tomography in Patients With Aortic Stenosis | 2.9 | 67 | Citations (PDF) |
| 144 | Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids | 4.2 | 4 | Citations (PDF) |
| 145 | Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin | 2.9 | 53 | Citations (PDF) |
| 146 | Family-Based Approaches to Cardiovascular Health Promotion | 2.3 | 88 | Citations (PDF) |
| 147 | Imaging of coronary atherosclerosis — evolution towards new treatment strategies | 35.5 | 56 | Citations (PDF) |
| 148 | GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo | 5.1 | 23 | Citations (PDF) |
| 149 | High-Risk Carotid Plaque Characteristics and Implications for Carotid Stenting | 1.8 | 0 | Citations (PDF) |
| 150 | Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial | 7.5 | 127 | Citations (PDF) |
| 151 | Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance | 2.3 | 89 | Citations (PDF) |
| 152 | Immune cell screening of a nanoparticle library improves atherosclerosis therapy | 7.5 | 110 | Citations (PDF) |
| 153 | Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease | 2.3 | 69 | Citations (PDF) |
| 154 | Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy | 13.7 | 129 | Citations (PDF) |
| 155 | The future of imaging in cardiovascular disease intervention trials: 2017 and beyond | 4.0 | 8 | Citations (PDF) |
| 156 | HDL mimetic CER-001 targets atherosclerotic plaques in patients | 1.5 | 59 | Citations (PDF) |
| 157 | Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study | 2.4 | 19 | Citations (PDF) |
| 158 | LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design | 3.1 | 45 | Citations (PDF) |
| 159 | In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models | 6.1 | 95 | Citations (PDF) |
| 160 | Imaging Atherosclerosis | 13.1 | 263 | Citations (PDF) |
| 161 | Systems Biology and Noninvasive Imaging of Atherosclerosis | 6.0 | 12 | Citations (PDF) |
| 162 | Attenuation Correction for Magnetic Resonance Coils in Combined PET/MR Imaging | 2.0 | 35 | Citations (PDF) |
| 163 | MR Imaging of Coronary Arteries and Plaques | 6.1 | 73 | Citations (PDF) |
| 164 | Does Vascular Calcification Accelerate Inflammation? | 2.3 | 50 | Citations (PDF) |
| 165 | Utility of Combining PET and MR Imaging of Carotid Plaque | 1.4 | 22 | Citations (PDF) |
| 166 | Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression | 5.5 | 25 | Citations (PDF) |
| 167 | A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis | 0.3 | 4 | Citations (PDF) |
| 168 | Three‐dimensional dynamic contrast‐enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques | 2.4 | 33 | Citations (PDF) |
| 169 | Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy | 3.6 | 44 | Citations (PDF) |
| 170 | Impact of Bariatric Surgery on Carotid Artery Inflammation and the Metabolic Activity in Different Adipose Tissues | 1.2 | 29 | Citations (PDF) |
| 171 | New Applications of Cardiac Computed Tomography | 6.1 | 156 | Citations (PDF) |
| 172 | Nanomedicines for endothelial disorders | 9.9 | 55 | Citations (PDF) |
| 173 | HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages | 3.8 | 159 | Citations (PDF) |
| 174 | Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events | 6.1 | 253 | Citations (PDF) |
| 175 | Atherosclerotic Plaque Targeting Mechanism of Long-Circulating Nanoparticles Established by Multimodal Imaging | 15.3 | 120 | Citations (PDF) |
| 176 | Elevated Serum Advanced Glycation Endproducts in Obese Indicate Risk for the Metabolic Syndrome: A Link Between Healthy and Unhealthy Obesity? | 4.0 | 139 | Citations (PDF) |
| 177 | A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome | 1.5 | 58 | Citations (PDF) |
| 178 | PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles | 5.1 | 162 | Citations (PDF) |
| 179 | Markerless attenuation correction for carotid MRI surface receiver coils in combined PET/MR imaging | 3.1 | 29 | Citations (PDF) |
| 180 | Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration | 3.6 | 163 | Citations (PDF) |
| 181 | The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial | 1.5 | 73 | Citations (PDF) |
| 182 | Imaging Systemic Inflammatory Networks in Ischemic Heart Disease | 2.3 | 77 | Citations (PDF) |
| 183 | HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages | 6.0 | 182 | Citations (PDF) |
| 184 | Manganese G8 dendrimers targeted to oxidation‐specific epitopes: In vivo MR imaging of atherosclerosis | 3.4 | 28 | Citations (PDF) |
| 185 | Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation | 10.9 | 216 | Citations (PDF) |
| 186 | Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis | 13.1 | 83 | Citations (PDF) |
| 187 | Effects of Pharmacotherapeutic Agents on Microembolization Rates During Carotid Revascularization | 0.7 | 0 | Citations (PDF) |
| 188 | Simultaneous carotid PET/MR: feasibility and improvement of magnetic resonance-based attenuation correction | 1.2 | 12 | Citations (PDF) |
| 189 | Labeling galectin-3 for the assessment of myocardial infarction in rats | 2.6 | 8 | Citations (PDF) |
| 190 | Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial | 2.2 | 236 | Citations (PDF) |
| 191 | Imaging and Nanomedicine in Inflammatory Atherosclerosis | 12.5 | 177 | Citations (PDF) |
| 192 | Attenuation Correction for Flexible Magnetic Resonance Coils in Combined Magnetic Resonance/Positron Emission Tomography Imaging | 6.8 | 36 | Citations (PDF) |
| 193 | Arterial and fat tissue inflammation are highly correlated : a prospective 18F-FDG PET/CT study | 5.5 | 54 | Citations (PDF) |
| 194 | Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study | 1.2 | 30 | Citations (PDF) |
| 195 | Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis | 7.5 | 185 | Citations (PDF) |
| 196 | Nanoparticle contrast agents for computed tomography: a focus on micelles | 1.9 | 330 | Citations (PDF) |
| 197 | A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting | 5.1 | 95 | Citations (PDF) |
| 198 | In Vivo Imaging of Enhanced Leukocyte Accumulation in Atherosclerotic Lesions in Humans | 2.3 | 44 | Citations (PDF) |
| 199 | Improvement of Attenuation Correction in Time-of-Flight PET/MR Imaging with a Positron-Emitting Source | 5.1 | 47 | Citations (PDF) |
| 200 | Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor Signaling | 18.0 | 50 | Citations (PDF) |
| 201 | Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression | 1.0 | 28 | Citations (PDF) |
| 202 | Brain Imaging Changes Associated With Risk Factors for Cardiovascular and Cerebrovascular Disease in Asymptomatic Patients | 6.1 | 103 | Citations (PDF) |
| 203 | Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia | 2.3 | 106 | Citations (PDF) |
| 204 | Imaging Plaques to Predict and Better Manage Patients With Acute Coronary Events | 13.1 | 51 | Citations (PDF) |
| 205 | Comparison of MR-based attenuation correction and CT-based attenuation correction of whole-body PET/MR imaging | 5.5 | 44 | Citations (PDF) |
| 206 | A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation | 13.7 | 393 | Citations (PDF) |
| 207 | Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation | 2.9 | 59 | Citations (PDF) |
| 208 | Noninvasive Assessment of Hypoxia in Rabbit Advanced Atherosclerosis Using
18
F-fluoromisonidazole Positron Emission Tomographic Imaging | 2.9 | 96 | Citations (PDF) |
| 209 | Synthesis and in vitro evaluation of a multifunctional and surface-switchable nanoemulsion platform | 3.4 | 16 | Citations (PDF) |
| 210 | The Complex Fate in Plasma of Gadolinium Incorporated into High-Density Lipoproteins Used for Magnetic Imaging of Atherosclerotic Plaques | 3.8 | 12 | Citations (PDF) |
| 211 | Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy | 3.8 | 111 | Citations (PDF) |
| 212 | Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation | 2.3 | 408 | Citations (PDF) |
| 213 | Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics | 15.3 | 116 | Citations (PDF) |
| 214 | Gold Nanocrystal Labeling Allows Low-Density Lipoprotein Imaging from the Subcellular to Macroscopic Level | 15.3 | 81 | Citations (PDF) |
| 215 | Near-Infrared Fluorescence Energy Transfer Imaging of Nanoparticle Accumulation and Dissociation Kinetics in Tumor-Bearing Mice | 15.3 | 66 | Citations (PDF) |
| 216 | The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and design | 2.9 | 100 | Citations (PDF) |
| 217 | Imaging of atherosclerosis: Can molecular imaging do more? | 1.5 | 4 | Citations (PDF) |
| 218 | The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis | 5.5 | 62 | Citations (PDF) |
| 219 | High-Dose Atorvastatin Reduces Periodontal Inflammation | 2.3 | 121 | Citations (PDF) |
| 220 | Multifunctional Gold Nanoparticles for Diagnosis and Therapy of Disease | 4.2 | 674 | Citations (PDF) |
| 221 | Relationship of Serum Inflammatory Biomarkers With Plaque Inflammation Assessed by FDG PET/CT | 6.1 | 72 | Citations (PDF) |
| 222 | Collagen-Specific Peptide Conjugated HDL Nanoparticles as MRI Contrast Agent to Evaluate Compositional Changes in Atherosclerotic Plaque Regression | 6.1 | 77 | Citations (PDF) |
| 223 | High-resolution magnetic resonance imaging of carotid atherosclerosis identifies vulnerable carotid plaques | 1.8 | 80 | Citations (PDF) |
| 224 | Comparison of Echocardiographic Measurements of Left Ventricular Volumes to Full Volume Magnetic Resonance Imaging in Normal and Diseased Rats | 3.4 | 23 | Citations (PDF) |
| 225 | Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality | 2.4 | 49 | Citations (PDF) |
| 226 | High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein | 7.5 | 6 | Citations (PDF) |
| 227 | Preclinical Evaluation of MR Attenuation Correction Versus CT Attenuation Correction on a Sequential Whole-Body MR/PET Scanner | 6.8 | 35 | Citations (PDF) |
| 228 | Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels | 5.5 | 123 | Citations (PDF) |
| 229 | Safety of CETP inhibition | 4.0 | 10 | Citations (PDF) |
| 230 | MRI-Based Attenuation Correction for Hybrid PET/MRI Systems: A 4-Class Tissue Segmentation Technique Using a Combined Ultrashort-Echo-Time/Dixon MRI Sequence | 5.1 | 392 | Citations (PDF) |
| 231 | The time has come for clinical cardiovascular trials with plaque characterization as an endpoint | 2.2 | 9 | Citations (PDF) |
| 232 | Evaluating Efficacy of Pharmaceutical Interventions in Atherosclerosis: Role of Magnetic Resonance Imaging and Positron Emission Tomography | 1.7 | 7 | Citations (PDF) |
| 233 | Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis | 1.5 | 29 | Citations (PDF) |
| 234 | The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis | 1.5 | 24 | Citations (PDF) |
| 235 | Association between kidney dysfuction and the severity of coronary and aortic atherosclerosis | 1.5 | 2 | Citations (PDF) |
| 236 | RR22. Magnetic Resonance Imaging for Identifying Vulnerable Carotid Plaques | 1.8 | 0 | Citations (PDF) |
| 237 | In Vivo Detection of Oxidation-Specific Epitopes in Atherosclerotic Lesions Using Biocompatible Manganese Molecular Magnetic Imaging Probes | 2.3 | 62 | Citations (PDF) |
| 238 | Impact of Noninsulin-Dependent Type 2 Diabetes on Carotid Wall 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake | 2.3 | 66 | Citations (PDF) |
| 239 | Increased Expression of Oxidation-Specific Epitopes and Apoptosis Are Associated With Haptoglobin Genotype | 2.3 | 40 | Citations (PDF) |
| 240 | Correlation Between Arterial FDG Uptake and Biomarkers in Peripheral Artery Disease | 6.1 | 60 | Citations (PDF) |
| 241 | Feasibility of [18F]-2-Fluoro-A85380-PET Imaging of Human Vascular Nicotinic Acetylcholine Receptors In Vivo | 6.1 | 30 | Citations (PDF) |
| 242 | Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945 | 6.1 | 73 | Citations (PDF) |
| 243 | Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis | 6.1 | 138 | Citations (PDF) |
| 244 | Detection of High-Risk Atherosclerotic Plaque | 6.1 | 222 | Citations (PDF) |
| 245 | Simultaneous PET–MRI in oncology: a solution looking for a problem? | 1.8 | 70 | Citations (PDF) |
| 246 | Nanoclusters of Iron Oxide: Effect of Core Composition on Structure, Biocompatibility, and Cell Labeling Efficacy | 3.8 | 14 | Citations (PDF) |
| 247 | Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging | 3.4 | 90 | Citations (PDF) |
| 248 | Molecular Imaging in Atherosclerosis: FDG PET | 4.7 | 76 | Citations (PDF) |
| 249 | Tumor Angiogenesis Phenotyping by Nanoparticle-facilitated Magnetic Resonance and Near-infrared Fluorescence Molecular Imaging | 7.0 | 29 | Citations (PDF) |
| 250 | Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices | 8.7 | 221 | Citations (PDF) |
| 251 | Cholesterol Efflux and Atheroprotection | 18.0 | 893 | Citations (PDF) |
| 252 | Noninvasive Cardiovascular Imaging in Rheumatoid Arthritis: Current Modalities and the Emerging Role of Magnetic Resonance and Positron Emission Tomography Imaging | 3.8 | 6 | Citations (PDF) |
| 253 | Letter to the Editor re: Spectral Hounsfield units—a new radiological concept | 3.6 | 6 | Citations (PDF) |
| 254 | Relationship between particulate matter exposure and atherogenic profile in “Ground Zero” workers as shown by dynamic contrast enhanced MR imaging | 1.2 | 10 | Citations (PDF) |
| 255 | Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis | 0.6 | 25 | Citations (PDF) |
| 256 | Imaging Atherosclerotic Plaques with MRI: Role of Contrast Agents | 0.6 | 2 | Citations (PDF) |
| 257 | Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases | 0.6 | 6 | Citations (PDF) |
| 258 | A Versatile and Tunable Coating Strategy Allows Control of Nanocrystal Delivery to Cell Types in the Liver | 3.8 | 41 | Citations (PDF) |
| 259 | Targeted Iron Oxide Particles for In Vivo Magnetic Resonance Detection of Atherosclerotic Lesions With Antibodies Directed to Oxidation-Specific Epitopes | 2.3 | 120 | Citations (PDF) |
| 260 | In Vivo Characterization of a New Abdominal Aortic Aneurysm Mouse Model With Conventional and Molecular Magnetic Resonance Imaging | 2.3 | 80 | Citations (PDF) |
| 261 | Use of Noninvasive Combined MRI-PET/CT Imaging in dal-PLAQUE to Assess Dalcetrapib's Effects on Structural and Inflammatory Atherosclerotic Disease | 3.1 | 0 | Citations (PDF) |
| 262 | Pioglitazone Modulates Vascular Inflammation in Atherosclerotic Rabbits | 6.1 | 77 | Citations (PDF) |
| 263 | Prevalence and Risk Factors of Carotid Vessel Wall Inflammation in Coronary Artery Disease Patients | 6.1 | 61 | Citations (PDF) |
| 264 | Imaging of Atherosclerosis | 18.7 | 114 | Citations (PDF) |
| 265 | Multifunctional Nanoemulsion Platform for Imaging Guided Therapy Evaluated in Experimental Cancer | 15.3 | 192 | Citations (PDF) |
| 266 | Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography | 2.9 | 52 | Citations (PDF) |
| 267 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis | 79.7 | 385 | Citations (PDF) |
| 268 | Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial | 62.1 | 512 | Citations (PDF) |
| 269 | Preclinical spectral computed tomography of gold nano-particles | 1.3 | 27 | Citations (PDF) |
| 270 | Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies | 4.7 | 10 | Citations (PDF) |
| 271 | Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases | 7.4 | 57 | Citations (PDF) |
| 272 | Noninvasive atherosclerosis imaging modalities and their application to investigating cardiovascular drug effects in rheumatoid arthritis | 3.4 | 0 | Citations (PDF) |
| 273 | The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis | 12.1 | 65 | Citations (PDF) |
| 274 | Science to Practice: Versatile Method to Track Transplanted Encapsulated Islet Cells with Multiple Imaging Modalities | 8.7 | 9 | Citations (PDF) |
| 275 | Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases | 2.2 | 54 | Citations (PDF) |
| 276 | Report of the National Heart, Lung, and Blood Institute Working Group on the Translation of Cardiovascular Molecular Imaging | 18.0 | 48 | Citations (PDF) |
| 277 | Diagnostic and therapeutic strategies for small abdominal aortic aneurysms | 35.5 | 72 | Citations (PDF) |
| 278 | Nanoparticle contrast agents for CT: their potential and the challenges that lie ahead | 0.3 | 19 | Citations (PDF) |
| 279 | MRI-based motion correction of thoracic PET: initial comparison of acquisition protocols and correction strategies suitable for simultaneous PET/MRI systems | 3.6 | 85 | Citations (PDF) |
| 280 | Nanomedical Theranostics in Cardiovascular Disease | 0.6 | 56 | Citations (PDF) |
| 281 | Modified natural nanoparticles as contrast agents for medical imaging | 15.4 | 183 | Citations (PDF) |
| 282 | Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis | 7.3 | 50 | Citations (PDF) |
| 283 | A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging | 1.9 | 112 | Citations (PDF) |
| 284 | Reproducibility of black blood dynamic contrast‐enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits | 3.4 | 34 | Citations (PDF) |
| 285 | Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging | 2.8 | 16 | Citations (PDF) |
| 286 | Variations in atherosclerosis and remodeling patterns in aorta and carotids | 4.3 | 32 | Citations (PDF) |
| 287 | Multifunctional imaging nanoprobes | 7.4 | 73 | Citations (PDF) |
| 288 | Magnetic Resonance Molecular Imaging of Thrombosis in an Arachidonic Acid Mouse Model Using an Activated Platelet Targeted Probe | 6.0 | 50 | Citations (PDF) |
| 289 | RGD peptide functionalized and reconstituted high‐density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe | 0.6 | 109 | Citations (PDF) |
| 290 | 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary | 18.0 | 367 | Citations (PDF) |
| 291 | The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction | 0.6 | 16 | Citations (PDF) |
| 292 | Atherosclerotic Plaque Composition: Analysis with Multicolor CT and Targeted Gold Nanoparticles | 8.7 | 470 | Citations (PDF) |
| 293 | High-Density Lipoprotein–Based Contrast Agents for Multimodal Imaging of Atherosclerosis | 6.0 | 110 | Citations (PDF) |
| 294 | 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults | 18.0 | 1,039 | Citations (PDF) |
| 295 | MRI of carotid atherosclerosis: clinical implications and future directions | 35.5 | 161 | Citations (PDF) |
| 296 | Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis | 4.2 | 162 | Citations (PDF) |
| 297 | Imaging Atherosclerotic Plaque Inflammation by Fluorodeoxyglucose With Positron Emission Tomography | 2.3 | 303 | Citations (PDF) |
| 298 | 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults | 2.3 | 1,232 | Citations (PDF) |
| 299 | 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary | 2.3 | 140 | Citations (PDF) |
| 300 | Annexin A5-Functionalized Bimodal Nanoparticles for MRI and Fluorescence Imaging of Atherosclerotic Plaques | 3.8 | 101 | Citations (PDF) |
| 301 | Quantum Dot and Cy5.5 Labeled Nanoparticles to Investigate Lipoprotein Biointeractions via Förster Resonance Energy Transfer | 8.7 | 76 | Citations (PDF) |
| 302 | Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis | 1.5 | 39 | Citations (PDF) |
| 303 | Increased Neovascularization in Advanced Lipid-Rich Atherosclerotic Lesions Detected by Gadofluorine-M-Enhanced MRI | 2.9 | 58 | Citations (PDF) |
| 304 | Multimodality Cardiovascular Molecular Imaging, Part II | 2.9 | 139 | Citations (PDF) |
| 305 | HDL as a contrast agent for medical imaging | 0.0 | 40 | Citations (PDF) |
| 306 | Nanotechnology in Medical Imaging | 6.0 | 275 | Citations (PDF) |
| 307 | Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers | 2.9 | 237 | Citations (PDF) |
| 308 | Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta | 35.5 | 33 | Citations (PDF) |
| 309 | Cardiovascular Molecular Imaging | 6.0 | 9 | Citations (PDF) |
| 310 | Inflammation Imaging in Atherosclerosis | 6.0 | 121 | Citations (PDF) |
| 311 | Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI | 2.2 | 28 | Citations (PDF) |
| 312 | Tyrosine polyethylene glycol (PEG)‐micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque | 2.8 | 34 | Citations (PDF) |
| 313 | Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging | 12.1 | 105 | Citations (PDF) |
| 314 | Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events | 4.3 | 60 | Citations (PDF) |
| 315 | High-Relaxivity Gadolinium-Modified High-Density Lipoproteins as Magnetic Resonance Imaging Contrast Agents | 2.7 | 65 | Citations (PDF) |
| 316 | Comparison of Synthetic High Density Lipoprotein (HDL) Contrast Agents for MR Imaging of Atherosclerosis | 3.8 | 67 | Citations (PDF) |
| 317 | Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis | 6.1 | 84 | Citations (PDF) |
| 318 | Comparison of In Vivo Carotid 3.0-T Magnetic Resonance to B-Mode Ultrasound Imaging and Histology in a Porcine Model | 6.1 | 8 | Citations (PDF) |
| 319 | In Vivo Detection of Embryonic Stem Cell–Derived Cardiovascular Progenitor Cells Using Cy3-Labeled Gadofluorine M in Murine Myocardium | 6.1 | 24 | Citations (PDF) |
| 320 | Well-Defined, Multifunctional Nanostructures of a Paramagnetic Lipid and a Lipopeptide for Macrophage Imaging | 15.0 | 30 | Citations (PDF) |
| 321 | Nanoparticulate Assemblies of Amphiphiles and Diagnostically Active Materials for Multimodality Imaging | 17.0 | 259 | Citations (PDF) |
| 322 | Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries | 1.5 | 149 | Citations (PDF) |
| 323 | Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging | 2.5 | 29 | Citations (PDF) |
| 324 | Comparison of 3D-diffusion-prepared segmented steady-state free precession and 2D fast spin echo imaging of femoral artery atherosclerosis | 1.2 | 9 | Citations (PDF) |
| 325 | An ApoA‐I Mimetic Peptide High‐Density‐Lipoprotein‐Based MRI Contrast Agent for Atherosclerotic Plaque Composition DetectionSmall, 2008, 4, 1437-1444 | 11.5 | 105 | Citations (PDF) |
| 326 | Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin‐binding intravascular contrast agent and MRI | 3.4 | 29 | Citations (PDF) |
| 327 | Fractionated feridex and positive contrast: In vivo MR imaging of atherosclerosis | 2.8 | 64 | Citations (PDF) |
| 328 | Serial in vivo positive contrast MRI of iron oxide‐labeled embryonic stem cell‐derived cardiac precursor cells in a mouse model of myocardial infarction | 2.8 | 61 | Citations (PDF) |
| 329 | Task force 13: Training in advanced cardiovascular imaging (computed tomography): Endorsed by the American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, and Society of Cardiovascular Computed Tomography | 1.7 | 0 | Citations (PDF) |
| 330 | Incorporation of an apoE‐derived lipopeptide in high‐density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis | 1.9 | 87 | Citations (PDF) |
| 331 | Paramagnetic Lipid-Coated Silica Nanoparticles with a Fluorescent Quantum Dot Core: A New Contrast Agent Platform for Multimodality Imaging | 3.8 | 149 | Citations (PDF) |
| 332 | Imaging of atherosclerotic cardiovascular disease | 37.9 | 532 | Citations (PDF) |
| 333 | Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform | 8.7 | 323 | Citations (PDF) |
| 334 | Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations | 5.1 | 433 | Citations (PDF) |
| 335 | Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia | 1.5 | 32 | Citations (PDF) |
| 336 | Imaging atherosclerotic plaque inflammation | 0.0 | 32 | Citations (PDF) |
| 337 | Improved Biocompatibility and Pharmacokinetics of Silica Nanoparticles by Means of a Lipid Coating: A Multimodality Investigation | 8.7 | 240 | Citations (PDF) |
| 338 | Multimodality nanotracers for cardiovascular applications | 0.0 | 48 | Citations (PDF) |
| 339 | Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes | 18.0 | 180 | Citations (PDF) |
| 340 | Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach | 6.0 | 151 | Citations (PDF) |
| 341 | “Feeling the RAGE” in the Atherosclerotic Vessel Wall | 2.9 | 1 | Citations (PDF) |
| 342 | Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET | 6.0 | 130 | Citations (PDF) |
| 343 | Multimodality Cardiovascular Molecular Imaging, Part I | 2.9 | 121 | Citations (PDF) |
| 344 | Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots | 7.3 | 145 | Citations (PDF) |
| 345 | In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis | 1.2 | 40 | Citations (PDF) |
| 346 | Detecting and assessing macrophagesin vivoto evaluate atherosclerosis noninvasively using molecular MRI | 7.5 | 349 | Citations (PDF) |
| 347 | ACCF/AHA 2007 Clinical Competence Statement on Vascular Imaging With Computed Tomography and Magnetic Resonance | 18.0 | 24 | Citations (PDF) |
| 348 | ACCF/AHA 2007 Clinical Competence Statement on vascular imaging with computed tomography and magnetic resonance | 2.4 | 8 | Citations (PDF) |
| 349 | Magnetic Resonance Molecular Imaging Contrast Agents and Their Application in Atherosclerosis | 0.7 | 26 | Citations (PDF) |
| 350 | Aortic Plaque Imaging and Monitoring Atherosclerotic Plaque Interventions | 0.7 | 19 | Citations (PDF) |
| 351 | Multimodality Imaging of Atherosclerosis (Magnetic Resonance Imaging/Computed Tomography/Positron Emission Tomography-Computed Tomography) | 0.7 | 7 | Citations (PDF) |
| 352 | Magnetic and fluorescent nanoparticles for multimodality imaging | 3.0 | 169 | Citations (PDF) |
| 353 | Response to ‘Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: No FDG accumulation’ [Atherosclerosis 2006] | 1.5 | 19 | Citations (PDF) |
| 354 | 18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible | 2.3 | 435 | Citations (PDF) |
| 355 | ACCF/AHA 2007 Clinical Competence Statement on Vascular Imaging With Computed Tomography and Magnetic Resonance | 2.3 | 31 | Citations (PDF) |
| 356 | Dépister la rupture de plaque : rêve ou réalité ? | 0.2 | 1 | Citations (PDF) |
| 357 | Non-invasive MRI of mouse models of atherosclerosis | 2.4 | 28 | Citations (PDF) |
| 358 | Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M | 1.9 | 81 | Citations (PDF) |
| 359 | CMR 2007: 1.05: MMP-Targeted Gd chelate for atherosclerotic imaging: experimental proof of concept | 1.9 | 0 | Citations (PDF) |
| 360 | Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG‐micelles | 2.8 | 131 | Citations (PDF) |
| 361 | Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes | 3.4 | 132 | Citations (PDF) |
| 362 | Automated classification of atherosclerotic plaque from magnetic resonance images using predictive models | 1.6 | 11 | Citations (PDF) |
| 363 | Serial magnetic resonance imaging correlates with neurological outcome in an experimental model of spinal cord ischemia | 1.9 | 3 | Citations (PDF) |
| 364 | Properties of a Versatile Nanoparticle Platform Contrast Agent To Image and Characterize Atherosclerotic Plaques by Magnetic Resonance Imaging | 8.7 | 162 | Citations (PDF) |
| 365 | Accuracy of 64-Slice Computed Tomography to Classify and Quantify Plaque Volumes in the Proximal Coronary System | 2.3 | 697 | Citations (PDF) |
| 366 | Task Force 12: Training in Advanced Cardiovascular Imaging (Computed Tomography) | 2.3 | 48 | Citations (PDF) |
| 367 | Clearance of Iron Oxide Particles in Rat Liver | 6.8 | 88 | Citations (PDF) |
| 368 | Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage | 1.8 | 17 | Citations (PDF) |
| 369 | Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): Sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T | 2.8 | 189 | Citations (PDF) |
| 370 | MRI to detect atherosclerosis with gadolinium‐containing immunomicelles targeting the macrophage scavenger receptor | 2.8 | 147 | Citations (PDF) |
| 371 | Feasibility of in vivo identification of endogenous ferritin with positive contrast MRI in rabbit carotid crush injury using GRASP | 2.8 | 33 | Citations (PDF) |
| 372 | Gadolinium mixed-micelles: Effect of the amphiphile on in vitro and in vivo efficacy in apolipoprotein E knockout mouse models of atherosclerosis | 2.8 | 36 | Citations (PDF) |
| 373 | Multislice dark-blood carotid artery wall imaging: A 1.5 T and 3.0 T comparison | 3.4 | 443 | Citations (PDF) |
| 374 | Carotid Black Blood MRI Burden of Atherosclerotic Disease Assessment Correlates with Ultrasound Intima-Media Thickness | 4.3 | 37 | Citations (PDF) |
| 375 | A Possible Association Between Coronary Plaque Instability and Complex Plaques in Abdominal Aorta | 6.0 | 28 | Citations (PDF) |
| 376 | Risk Scores Predict Atherosclerotic Lesions in Young People | 8.1 | 198 | Citations (PDF) |
| 377 | Atherosclerotic Plaque Imaging | 8.1 | 30 | Citations (PDF) |
| 378 | Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results | 3.6 | 140 | Citations (PDF) |
| 379 | Comparison of gated and nongated fast multislice black-blood carotid imaging using rapid extended coverage and inflow/outflow saturation techniques | 3.4 | 41 | Citations (PDF) |
| 380 | Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent | 18.0 | 153 | Citations (PDF) |
| 381 | Long-term Air Pollution Exposure and Acceleration of Atherosclerosis and Vascular Inflammation in an Animal Model | 16.5 | 776 | Citations (PDF) |
| 382 | Tracking atherosclerosis regression: a clinical tool in preventive cardiology | 1.5 | 43 | Citations (PDF) |
| 383 | Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging | 1.5 | 73 | Citations (PDF) |
| 384 | Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging | 2.3 | 145 | Citations (PDF) |
| 385 | Does shear stress modulate both plaque progression and regression in the thoracic aorta? | 2.3 | 137 | Citations (PDF) |
| 386 | Effects of Aggressive Versus Conventional Lipid-Lowering Therapy by Simvastatin on Human Atherosclerotic Lesions | 2.3 | 262 | Citations (PDF) |
| 387 | Atherothrombosis and High-Risk Plaque | 2.3 | 702 | Citations (PDF) |
| 388 | Atherothrombosis and High-Risk Plaque | 2.3 | 161 | Citations (PDF) |
| 389 | In Vivo 16-Slice, Multidetector-Row Computed Tomography for the Assessment of Experimental Atherosclerosis | 18.0 | 64 | Citations (PDF) |
| 390 | Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging | 18.0 | 199 | Citations (PDF) |
| 391 | Serial Studies of Mouse Atherosclerosis by In Vivo Magnetic Resonance Imaging Detect Lesion Regression After Correction of Dyslipidemia | 6.0 | 88 | Citations (PDF) |
| 392 | Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging | 0.0 | 46 | Citations (PDF) |
| 393 | Prenatal Detection of Embryo Resorption in Osteopontin-Deficient Mice Using Serial Noninvasive Magnetic Resonance Microscopy | 2.2 | 39 | Citations (PDF) |
| 394 | Molecular, cellular and functional imaging of atherothrombosis | 79.7 | 238 | Citations (PDF) |
| 395 | Optimization of ex vivo CT- and MR- Imaging of Atherosclerotic Vessel Wall Changes | 0.0 | 6 | Citations (PDF) |
| 396 | Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque | 4.7 | 27 | Citations (PDF) |
| 397 | Parallel and nonparallel simultaneous multislice black-blood double inversion recovery techniques for vessel wall imaging | 3.4 | 48 | Citations (PDF) |
| 398 | Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images | 2.8 | 74 | Citations (PDF) |
| 399 | Recombinant HDL-Like Nanoparticles: A Specific Contrast Agent for MRI of Atherosclerotic Plaques | 15.0 | 311 | Citations (PDF) |
| 400 | In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography | 2.9 | 73 | Citations (PDF) |
| 401 | Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries | 1.5 | 102 | Citations (PDF) |
| 402 | Magnetic resonance imaging of coronary atherosclerosis | 4.7 | 5 | Citations (PDF) |
| 403 | Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling | 3.4 | 31 | Citations (PDF) |
| 404 | Magnetic resonance microscopy quantifies the disease progression in Marfan syndrome mice | 3.4 | 8 | Citations (PDF) |
| 405 | Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes | 3.8 | 40 | Citations (PDF) |
| 406 | Vascular MRI in the Diagnosis and Therapy of the High Risk Atherosclerotic Plaque | 1.3 | 12 | Citations (PDF) |
| 407 | Complementary results of computed tomography and magnetic resonance imaging of the heart and coronary arteries: a review and future outlook | 1.5 | 26 | Citations (PDF) |
| 408 | Mouse model of heterotopic aortic arch transplantation | 1.6 | 66 | Citations (PDF) |
| 409 | MR imaging for the noninvasive assessment of atherothrombotic plaques | 1.4 | 42 | Citations (PDF) |
| 410 | From Vulnerable Plaque to Vulnerable Patient | 18.0 | 2,451 | Citations (PDF) |
| 411 | From Vulnerable Plaque to Vulnerable Patient | 18.0 | 1,605 | Citations (PDF) |
| 412 | A Novel Nonobstructive Intravascular MRI Coil | 6.0 | 50 | Citations (PDF) |
| 413 | Statins and Plaque Stability | 2.2 | 4 | Citations (PDF) |
| 414 | Title is missing! | 2.2 | 8 | Citations (PDF) |
| 415 | Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging | 18.0 | 270 | Citations (PDF) |
| 416 | Coronary Wall Imaging with MRI | 2.2 | 5 | Citations (PDF) |
| 417 | Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions | 18.0 | 474 | Citations (PDF) |
| 418 | Cardiac magnetic resonance imaging: a “one-stop-shop” evaluation of myocardial dysfunction | 1.6 | 50 | Citations (PDF) |
| 419 | Title is missing! | 2.2 | 10 | Citations (PDF) |
| 420 | MRI and Characterization of Atherosclerotic Plaque | 6.0 | 142 | Citations (PDF) |
| 421 | In vivo noninvasive detection and age definition of arterial thrombus by MRI | 2.3 | 127 | Citations (PDF) |
| 422 | Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy | 1.5 | 58 | Citations (PDF) |
| 423 | Noncoronary and coronary atherothrombotic plaque imaging and monitoring of therapy by MRI | 1.4 | 17 | Citations (PDF) |
| 424 | Atherothrombotic plaques and the need for imaging | 1.4 | 9 | Citations (PDF) |
| 425 | Utility of cardiovascular magnetic resonance imaging | 0.9 | 0 | Citations (PDF) |
| 426 | Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits | 2.3 | 102 | Citations (PDF) |
| 427 | Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E–deficient mouse in a novel transplantation model | 1.8 | 129 | Citations (PDF) |
| 428 | Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque | 13.1 | 485 | Citations (PDF) |
| 429 | Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences | 9.6 | 259 | Citations (PDF) |
| 430 | Title is missing! 2001, 17, 165-177 | | 36 | Citations (PDF) |
| 431 | Title is missing! | 0.0 | 12 | Citations (PDF) |
| 432 | New Understanding of Atherosclerosis (Clinically and Experimentally) with Evolving MRI Technology in Vivo | 4.0 | 61 | Citations (PDF) |
| 433 | Predicting plaque rupture: enhancing diagnosis and clinical decision-making in coronary artery disease | 2.4 | 19 | Citations (PDF) |
| 434 | Imaging for plaque instability—Novel MR imaging techniques | 1.8 | 0 | Citations (PDF) |
| 435 | High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model | 1.5 | 94 | Citations (PDF) |
| 436 | Characterization of Atherosclerotic Plaques by Magnetic Resonance Imaging | 4.0 | 160 | Citations (PDF) |
| 437 | Effect of dobutamine on regional left ventricular function measured by tagged magnetic resonance imaging in normal subjects | 1.8 | 53 | Citations (PDF) |
| 438 | Acute Coronary Syndromes: Pathophysiology and Preventive Priorities | 4.1 | 37 | Citations (PDF) |
| 439 | Right ventricular regional function using MR tagging: Normals versus chronic pulmonary hypertension | 2.8 | 73 | Citations (PDF) |
| 440 | Integrated MRI assessment of regional function and perfusion in canine myocardial infarction | 2.8 | 31 | Citations (PDF) |
| 441 | Global cardiac function using fast breath-hold MRI: Validation of new acquisition and analysis techniques | 2.8 | 89 | Citations (PDF) |
| 442 | Absolute right and left ventricular volume and ejection fraction measurements by tomographic MUGA | 2.3 | 0 | Citations (PDF) |
| 443 | An improved quadrature or phased-array coil for MR cardiac imaging | 2.8 | 62 | Citations (PDF) |
| 444 | 929-64 Global Cardiac Function Using Active Contour Models with Fast Breath-hold MRI | 2.3 | 2 | Citations (PDF) |
| 445 | Radiolabeling lipoproteins to study and manage disease | 5.5 | 1 | Citations (PDF) |
| 446 | Imaging Findings Associated With Socioenvironmental Exposures Inform Mechanisms of Cardiovascular Disease | 6.0 | 4 | Citations (PDF) |
| 447 | Cardiac Deformation Patterns During Exercise in Healthy Children | 1.4 | 0 | Citations (PDF) |
| 448 | Systemically inducing trained immunity overcomes solid tumors’ immunosuppressive microenvironment | 10.9 | 5 | Citations (PDF) |
| 449 | Sarcoidosis Masquerading as Hypertrophic Cardiomyopathy | 0.5 | 0 | Citations (PDF) |
| 450 | AI-derived left-to-right cardiac chamber volume ratios in coronary artery calcium scans strongly predict heart failure | 1.4 | 0 | Citations (PDF) |
| 451 | Role of digital twins in longevity medicine 0, 1, 100002 | | 0 | Citations (PDF) |
| 452 | Wearable technologies in clinical trials for drug development: trends and emerging opportunities | 79.7 | 0 | Citations (PDF) |
| 453 | Corrigendum to ‘Anomalous Attachment of the Posterior Mitral Annulus to the Crest of the Left Ventricle in Patients with Mitral Annular Disjunction (MAD) and Mitral Valve Prolapse’[The American Journal of Cardiology 263 (2026) 27-32] | 1.8 | 0 | Citations (PDF) |
